Antineoplastic-dendritic polymer drug delivery system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060039891A1
SERIAL NO

10493354

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antineoplastic dendritic polymer conjugates which are useful drug delivery systems for carrying antineoplastic agents to malignant tumors are prepared. The antineoplastic agent is encapsulated within the dendritic polymer using an ionic charge shunt mechanism, whereby, the antineoplastic agent interacts with the anionic functional groups on the surface of the dendritic polymer allowing the antineoplastic agent to be uptaken by the dendritic polymer through an association with the functional groups of the interior of the dendritic polymer. The antineoplastic dendritic polymer conjugates may be administered intravenously, orally, parentally, subcutaneously, intraarterially or topically to an animal having a malignant tumor in an amount which is effective to inhibit growth of the malignant tumor. The antineoplastic dendritic polymer conjugates exhibit high drug efficiency, high drug carrying capacity, good water solubility, good stability on storage, and reduced toxicity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DENDRITIC NANOTECHNOLOGIES INC2625 DENISON DRIVE SUITE B M T PLEASANT MI 48858

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Duncan, Ruth London, GB 15 265
Esfand, Roseita Mr. Pleasnt, MI 24 294
Malik, Navid Kilburn, GB 5 38
Tomalia, Donald A Midland, MI 72 4037

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation